Thyroid Stimulating but Not Blocking Autoantibodies Are Highly Prevalent in Severe and Active Thyroid-Associated Orbitopathy: A Prospective Study

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Kampmann, E ^a   Diana, T ^a   Kanitz, M ^a   Hoppe, D ^b   Kahaly, G J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; THYROID BINDING INHIBITORY IMMUNOGLOBULIN; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; DIPLOPIA; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYELID RETRACTION; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84937019962     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/678194     Document Type: Article

References (24)

1. C. Marcocci, L. Bartalena, F. Bogazzi, M. Panicucci, and A. Pinchera, "Studies on the occurrence of ophthalmopathy in Graves' disease, " Acta Endocrinologica, vol. 120, no. 4, pp. 473-478, 1989.
2. G. B. Bartley and C. A. Gorman, "Diagnostic criteria for Graves' ophthalmopathy, " The American Journal of Ophthalmology, vol. 119, no. 6, pp. 792-795, 1995.
3. M. P. Mourits, L. Koornneef, W. M. Wiersinga, M. F. Prummel, A. Berghout, and R. van der Gaag, "Clinical criteria for the assessment of disease activity inGraves' ophthalmology: a novel approach, " The British Journal of Ophthalmology, vol. 73, no. 8, pp. 639-644, 1989.
4. S. C. Werner, "Modification of the classification of the eye changes of Graves' disease, " The American Journal of Ophthalmology, vol. 83, no. 5, pp. 725-727, 1977.
5. W. M. Wiersinga, "Quality of life in Graves' ophthalmopathy, " Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 26, no. 3, pp. 359-370, 2012.
6. K. A. Ponto, G. Hommel, S. Pitz, H. Elflein, N. Pfeiffer, and G. J. Kahaly, "Quality of life in a German graves orbitopathy population, " The American Journal of Ophthalmology, vol. 152, no. 3, pp. 483-490, 2011.
7. L. Bartalena, A. Pinchera, and C. Marcocci, "Management of Graves' ophthalmopathy: reality and perspectives, " Endocrine Reviews, vol. 21, no. 2, pp. 168-199, 2000.
8. S. Y. Goh, S. C. Ho, L. L. Seah, K. S. Fong, and D. H. C. Khoo, "Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Grave's disease differ and suggest ophthalmopathy is a multiantigenic disease, " Clinical Endocrinology, vol. 60, no. 5, pp. 600-607, 2004.
9. Y. Li, J. Kim, T. Diana, R. Klasen, P. D. Olivo, and G. J. Kahaly, "A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity, " Clinical and Experimental Immunology, vol. 173, no. 3, pp. 390-397, 2013.
10. K. Kamijo, H. Murayama, T. Uzu, K. Togashi, P. D. Olivo, and G. J. Kahaly, "Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease, " Thyroid, vol. 21, no. 12, pp. 1295-1299, 2011.
11. J. J. Leschik, T. Diana, P. D. Olivo et al., "Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins, "The American Journal of Clinical Pathology, vol. 139, no. 2, pp. 192-200, 2013.
12. G. J. Kahaly, O. Shimony, Y. N. Gellman et al., "Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin, " The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 2, pp. 422-429, 2011.
13. A. K. Eckstein, A. Finkenrath, A. Heiligenhaus et al., "Dry eye syndrome in thyroid-associated ophthalmopathy: Lacrimal expression of TSH receptor suggests involvement of TSHRspecific autoantibodies, " Acta Ophthalmologica Scandinavica, vol. 82, no. 3, pp. 291-297, 2004.
14. A. K. Eckstein, M. Plicht, H. Lax et al., "Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease, " The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3464-3470, 2006.
15. S. Y. Jang, D. Y. Shin, E. J. Lee, Y. J. Choi, S. Y. Lee, and J. S. Yoon, "Correlation between TSHreceptor antibody assays and clinical manifestations of Graves' orbitopathy, " Yonsei Medical Journal, vol. 54, no. 4, pp. 1033-1039, 2013.
16. M. N. Gerding, J. W. C. van der Meer, M. Broenink, O. Bakker, W. M. Wiersinga, and M. F. Prummel, "Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy, " Clinical Endocrinology, vol. 52, no. 3, pp. 267-271, 2000.
17. D. H. C. Khoo, S. C. Ho, L. L. Seah et al., "The combination of absent thyroid peroxidase antibodies and high thyroidstimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy, "Thyroid, vol. 9, no. 12, pp. 1175-1180, 1999.
18. I. Subekti, A.Boedisantoso, N. D. Moeloek, S.Waspadji, andM. Mansyur, "Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy, " Acta Medica Indonesiana, vol. 44, no. 2, pp. 114-121, 2012.
19. L. R. Dragan, S. R. Seiff, andD.C. Lee, "Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy, " Ophthalmic Plastic and Reconstructive Surgery, vol. 22, no. 1, pp. 13-19, 2006.
20. S. D. Lytton, Y. Li, P. D. Olivo, L. D. Kohn, and G. J. Kahaly, "Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulin, " Clinical & Experimental Immunology, vol. 162, no. 3, pp. 438-446, 2010.
21. R. S. Bahn, "Graves' ophthalmopathy, "The New England Journal of Medicine, vol. 362, no. 8, pp. 726-738, 2010.
22. M.-C. Many, S. Costagliola, M. Detrait, J.-F. Denef, G. Vassart, and M. Ludgate, "Development of an animal model of autoimmune thyroid eye disease, " Journal of Immunology, vol. 162, no. 8, pp. 4966-4974, 1999.
23. J. Y. Noh, N. Hamada, Y. Inoue, Y. Abe, K. Ito, and K. Ito, "Thyroid-stimulating antibody is related to graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease, " Thyroid, vol. 10, no. 9, pp. 809-813, 2000.
24. L. Bartalena, L. Baldeschi, A. J. Dickinson et al., "Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy, " Thyroid, vol. 18, no. 3, pp. 333-346, 2008.